CClinicalTrials.gg
CompletedNCT03021096TSAUpdated Mar 4, 2025Results posted

Natural History of Pain After Shoulder Arthroplasty Conducted With Multimodal Analgesia

An observational study in TSA, Bruise and Pain, Postoperative, sponsored by Hospital for Special Surgery, New York. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-04.

Sponsored by Hospital for Special Surgery, New York · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
108
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to identify the timeline of pain following total shoulder replacement with the goal of developing data for a subsequent randomized trial. The investigators believe that with using HSS's current protocol, many patients have postoperative pain that is no worse than their preoperative pain. Previous HSS anesthesia protocols for total shoulder arthroplasty patients have not formally followed patients past their hospital discharge, and the investigators believe that some patients do experience moderate to severe subacute postoperative pain. Therefore, this study's primary outcome is to look at the numeric pain scores at 14 days after surgery. Future studies will look at measures of preventing bruising and subsequent pain after shoulder replacement.

Read the detailed description

This is a pilot study, with the goals of

  1. developing data for a subsequent randomized trials
  2. describing the pain trajectory after total shoulder arthroplasty given comprehensive multimodal perioperative analgesia
  3. gathering preliminary data about which shoulder arthroplasty patients are at high risk for moderate or severe postoperative pain (NRS with movement, POD14, moderate >= 4- 6; Gerbershagen 2011; severe >= 7-10, Krebs 2007) Potential factors include fibromyalgia score, catastrophizing score, anxiety/depression score, gender, preoperative opioid use
  4. gathering preliminary data on the potential association between the predictors listed in (c) and NRS pain score with movement on POD 14.
  5. estimating incidence and severity of postoperative bruising on POD 14
02

Conditions studied

  • TSA
  • Bruise
  • Pain, Postoperative

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 108 is close to the median of 102 across 608 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 217 studies on the registry; 39 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 20 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients undergoing TSA for Osteoarthritis, Reverse, Anatomic procedures

Inclusion criteria

  • All patients eligible for the standardized anesthetic for TSA
  • Patients who are capable to provide informed consent and answer questions in English (Study involves questionnaires validated in English)
  • Age 18-80

Exclusion criteria

Exclusion Criteria:

  • Incapable to provide informed consent
  • Contraindications for regional anesthesia (anticoagulation, infection at injection site)
  • Patients undergoing TSA for Trauma or Rheumatoid Arthritis
  • Revision TSA (previous non-TSA surgery is not an exclusion)
  • Conversion of hemiarthroplasty to TSA
  • Planned use of tranexamic acid
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
108 participants (actual)
Patient registry
No

Interventions

  • OtherSurveys

    The study is just using validated surveys to assess pain and mood states after surgery

06

What researchers measure

Primary outcomes

  1. Numeric Rating Scale Pain Scores at Post-operative Day 14

    Quantifying patients' pain at a sub-acute time point after surgery at rest and with movement. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

    Time frame: 14 days after surgery for each patient

Secondary outcomes

  1. Numeric Rating Scale (NRS) Pain With Movement and at Rest.

    The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable". A lower score is a better outcome.

    Time frame: Days 1 day (POD0), 3 days(POD3), 7 days(POD7) and 3 months(POD90) after surgery

  2. Opioid Consumption (in Past 24 Hours)

    Measured in milligrams taken. A lower consumption is a better outcome.

    Time frame: Days 1 day, 3 days, 7 days after surgery

  3. Opioid Related Symptom Distress Scale

    The Opioid-Related Symptom Distress Scale (ORSDS) is calculated by taking the average of the three symptom distress dimensions. Frequency will be assessed using a 4 point scale: 1, rarely 2, occasionally 3, frequently 4, almost constantly with 1 being the lowest and 4 being the highest. Severity is assessed using a 4 point scale: 1, slight 2, moderate 3, severe 4, very severe with 1 being the lowest and 4 being the highest. Bothersomeness is assessed using a 5 point scale: 1, not at all 2, a little bit 3, somewhat 4, quite a bit 5, very much with 1 being the lowest and 5 being the highest. A higher score indicates worse outcomes. The total score for each participant is calculated and the median score for all participants is reported.

    Time frame: Day 1 after surgery

  4. Range of Motion

    Measure the ability of shoulder movement from 0 to 180 degrees at these follow up visits with the surgeon after surgery.

    Time frame: Day 14 after surgery and 3 months after surgery

  5. Severity of Bruising

    Surgeon will assess each individual patient to determine whether bruising occurred and if so, the size and severity of the bruise.

    Time frame: Day 14 after surgery

  6. Hospital Anxiety and Depression Scale

    The Hospital Anxiety and Depression Scale (HADS) measures anxiety and depression in a general medical population of patients. a lower score is a better outcome. Each item on the questionnaire is scored from 0-3 and a person's total score can ranged from 0 = normal and 21 = abnormal for either anxiety or depression. Scale range: 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case) A total score for each participant was calculated and then all participants' scores were averaged.

    Time frame: Day 1 after surgery

  7. PainOUT Questionnaire

    The PainOUT questionnaire assess pain intensity, quality of pain, and satisfaction with pain management. The questionnaire measured the following: 1. Worst pain: On a 0-10 scale, where 0 means "no pain" and 10 means "worst possible pain". Higher scores reflect more severity. 2. Pain severity: On a scale 0-10, where 0 means "very unsatisfied" and 10 means "very satisfied". Higher scores means more satisfaction. 3. Interference with sleep: Rated on a 0-10 scale, where 0 means "does not interfere" and 10 means "completely interfere" A higher rating means more interference. 4. Nausea \& Itching: Both rated on a 0-10 scale, where 0 means "none" and 10 means "severe". A higher rating means more severe. 5. Drowsiness: Rated on a 0-10 scale, where 0 means "not at all" and 10 means "extremely". A higher rating means more severe. Each question score for each participant was added up and divided by the total number of participants to obtain an average score of 0-10 at each timepoint.

    Time frame: Day 1 and 14 after surgery

  8. Pain Catastrophizing Scale (PCS)

    The pain catastrophizing scale (PCS) evaluates a person's pain experience by asking them how they feel and what they think about when they are in pain. The questionnaire uses a 5-point Likert scale, with answers ranging from 0 (never) to 4. (always). The total score is the sum of the individual item scores and ranges from 0 to 52. A lower score indicates a more positive outcome.

    Time frame: Day of Surgery

  9. Fibromyalgia Scale. a Lower Score is a Better Outcome.

    The symptom severity (SS) scale assesses four symptoms that are thought to be defining in a fibromyalgia diagnosis. The four symptoms assessed by the criteria are as follows: 1. Fatigue 2. Waking from sleep feeling unrefreshed 3. Cognitive symptoms (including trouble concentrating, confusion, disorientation, and impaired comprehension) 4. Somatic symptoms (physical sensations such as pain, dizziness, nausea, fainting, or bowel disorders) Each of the 4 symptoms is graded on a scale of 0 to 3, with 0 indicating no symptoms, 1 indicating mild symptoms, 2 indicating moderate symptoms, and 3 indicating severe symptoms. The sum of the scores for each of the 4 symptoms is summed to produce the SS total score. The SS total score has a minimum score of 0 and a maximum score of 12. The higher score means worst outcome. The sum score for each participant is calculated and then the average score for all participants is reported.

    Time frame: Day of Surgery

07

Results

Posted Mar 4, 2025

Participant flow

Participant flow — Overall Study
MilestoneTotal Shoulder Surgery Patients
Started108
Completed102
Not completed6
Withdrew: Lost to follow-up4
Withdrew: Protocol violation2

Outcome measures

PrimaryNumeric Rating Scale Pain Scores at Post-operative Day 14

Quantifying patients' pain at a sub-acute time point after surgery at rest and with movement. The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable".

Time frame:
14 days after surgery for each patient
Reported as:
Mean · score on a scale
Numeric Rating Scale Pain Scores at Post-operative Day 14
score on a scaleTotal Shoulder Surgery Patients
NRS at rest1.6 ± 1.8
NRS with movement3.1 ± 2.3
SecondaryNumeric Rating Scale (NRS) Pain With Movement and at Rest.

The numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable". A lower score is a better outcome.

Time frame:
Days 1 day (POD0), 3 days(POD3), 7 days(POD7) and 3 months(POD90) after surgery
Reported as:
Mean · score on a scale
Numeric Rating Scale (NRS) Pain With Movement and at Rest.
score on a scaleTotal Shoulder Surgery Patients
NRS POD1 at rest1.6 ± 2.1
NRS POD1 with movement2.7 ± 3
NRS POD3 at rest2.8 ± 3.3
NRS POD3 with movement4.7 ± 2.4
NRS POD7 at rest2.3 ± 2.4
NRS POD7 with movement3.9 ± 2.3
NRS POD90 at rest0.8 ± 1.7
NRS POD90 with movement1.7 ± 2.2
SecondaryOpioid Consumption (in Past 24 Hours)

Measured in milligrams taken. A lower consumption is a better outcome.

Time frame:
Days 1 day, 3 days, 7 days after surgery
Reported as:
Median · oral morphine equivalents (mg)
Opioid Consumption (in Past 24 Hours)
oral morphine equivalents (mg)Total Shoulder Surgery Patients
POD117.5 (3.9 to 50.1)
POD330 (7.4 to 63.2)
POD710 (0 to 37.5)
SecondaryOpioid Related Symptom Distress Scale

The Opioid-Related Symptom Distress Scale (ORSDS) is calculated by taking the average of the three symptom distress dimensions. Frequency will be assessed using a 4 point scale: 1, rarely 2, occasionally 3, frequently 4, almost constantly with 1 being the lowest and 4 being the highest. Severity is assessed using a 4 point scale: 1, slight 2, moderate 3, severe 4, very severe with 1 being the lowest and 4 being the highest. Bothersomeness is assessed using a 5 point scale: 1, not at all 2, a little bit 3, somewhat 4, quite a bit 5, very much with 1 being the lowest and 5 being the highest. A higher score indicates worse outcomes. The total score for each participant is calculated and the median score for all participants is reported.

Time frame:
Day 1 after surgery
Reported as:
Median · score on a scale
Opioid Related Symptom Distress Scale
score on a scaleTotal Shoulder Surgery Patients
Opioid Related Symptom Distress Scale0.3 (0.1 to 0.5)
SecondaryRange of Motion

Measure the ability of shoulder movement from 0 to 180 degrees at these follow up visits with the surgeon after surgery.

Time frame:
Day 14 after surgery and 3 months after surgery
Reported as:
Mean · degrees
Range of Motion
degreesTotal Shoulder Surgery Patients
14 days after surgery extension15.8 ± 5.8
3 months after surgery extension35 ± 21.2
SecondarySeverity of Bruising

Surgeon will assess each individual patient to determine whether bruising occurred and if so, the size and severity of the bruise.

Time frame:
Day 14 after surgery
Reported as:
Mean · cm
Severity of Bruising
cmTotal Shoulder Surgery Patients
Severity of Bruising1.5 ± 1.9
SecondaryHospital Anxiety and Depression Scale

The Hospital Anxiety and Depression Scale (HADS) measures anxiety and depression in a general medical population of patients. a lower score is a better outcome. Each item on the questionnaire is scored from 0-3 and a person's total score can ranged from 0 = normal and 21 = abnormal for either anxiety or depression. Scale range: 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case) A total score for each participant was calculated and then all participants' scores were averaged.

Time frame:
Day 1 after surgery
Reported as:
Mean · score on a scale
Hospital Anxiety and Depression Scale
score on a scaleTotal Shoulder Surgery Patients
Anxiety4.1 ± 3.3
Depression3.9 ± 2.7
SecondaryPainOUT Questionnaire

The PainOUT questionnaire assess pain intensity, quality of pain, and satisfaction with pain management. The questionnaire measured the following: 1. Worst pain: On a 0-10 scale, where 0 means "no pain" and 10 means "worst possible pain". Higher scores reflect more severity. 2. Pain severity: On a scale 0-10, where 0 means "very unsatisfied" and 10 means "very satisfied". Higher scores means more satisfaction. 3. Interference with sleep: Rated on a 0-10 scale, where 0 means "does not interfere" and 10 means "completely interfere" A higher rating means more interference. 4. Nausea \& Itching: Both rated on a 0-10 scale, where 0 means "none" and 10 means "severe". A higher rating means more severe. 5. Drowsiness: Rated on a 0-10 scale, where 0 means "not at all" and 10 means "extremely". A higher rating means more severe. Each question score for each participant was added up and divided by the total number of participants to obtain an average score of 0-10 at each timepoint.

Time frame:
Day 1 and 14 after surgery
Reported as:
Mean · score on a scale
PainOUT Questionnaire
score on a scaleTotal Shoulder Surgery Patients
POD1 - Worst pain2 (0 to 5)
POD14 - Worst pain4 (2 to 6)
POD1 - Pain severity0 (0 to 0)
POD14 - Pain severity0 (0 to 10)
POD1 - Interference with sleep0 (0 to 2)
POD14 - Interference with sleep0 (0 to 5)
POD1 - Nausea0 (0 to 0)
POD14 - Nausea0 (0 to 0)
POD1 - Itching0 (0 to 0)
POD14 - Itching0 (0 to 1)
POD1 - Drowsiness0 (0 to 5)
POD14 - Drowsiness0 (0 to 2)
SecondaryPain Catastrophizing Scale (PCS)

The pain catastrophizing scale (PCS) evaluates a person's pain experience by asking them how they feel and what they think about when they are in pain. The questionnaire uses a 5-point Likert scale, with answers ranging from 0 (never) to 4. (always). The total score is the sum of the individual item scores and ranges from 0 to 52. A lower score indicates a more positive outcome.

Time frame:
Day of Surgery
Reported as:
Mean · score on a scale
Pain Catastrophizing Scale (PCS)
score on a scaleTotal Shoulder Surgery Patients
Pain Catastrophizing Scale (PCS)12 ± 11.9
SecondaryFibromyalgia Scale. a Lower Score is a Better Outcome.

The symptom severity (SS) scale assesses four symptoms that are thought to be defining in a fibromyalgia diagnosis. The four symptoms assessed by the criteria are as follows: 1. Fatigue 2. Waking from sleep feeling unrefreshed 3. Cognitive symptoms (including trouble concentrating, confusion, disorientation, and impaired comprehension) 4. Somatic symptoms (physical sensations such as pain, dizziness, nausea, fainting, or bowel disorders) Each of the 4 symptoms is graded on a scale of 0 to 3, with 0 indicating no symptoms, 1 indicating mild symptoms, 2 indicating moderate symptoms, and 3 indicating severe symptoms. The sum of the scores for each of the 4 symptoms is summed to produce the SS total score. The SS total score has a minimum score of 0 and a maximum score of 12. The higher score means worst outcome. The sum score for each participant is calculated and then the average score for all participants is reported.

Time frame:
Day of Surgery
Reported as:
Mean · score on a scale
Fibromyalgia Scale. a Lower Score is a Better Outcome.
score on a scaleTotal Shoulder Surgery Patients
Fibromyalgia Scale. a Lower Score is a Better Outcome.5.5 ± 3.4

Adverse events

Collected over 3 months after surgery. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Total Shoulder Surgery Patients0/108 (0%)0/108 (0%)0/108 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Total Shoulder Surgery Patients
Mean66 ± 9
Sex: Female, Male
Sex: Female, Male(Participants)Total Shoulder Surgery Patients
Female48
Male54
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Total Shoulder Surgery Patients
08

Study locations

1 site
  • Hospital for Special Surgery
    New York, New York 10021, United States
09

References and documents

Publications

  • Goon AK, Dines DM, Craig EV, Gordon MA, Goytizolo EA, Lin Y, Lin E, YaDeau JT. A clinical pathway for total shoulder arthroplasty-a pilot study. HSS J. 2014 Jul;10(2):100-6. doi: 10.1007/s11420-014-9381-0. Epub 2014 Mar 8. PubMed 25050091 ↗
  • YaDeau JT, Gordon MA, Goytizolo EA, Lin Y, Fields KG, Goon AK, Holck G, Miu TW, Gulotta LV, Dines DM, Craig EV. Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study. Pain Med. 2016 May;17(5):940-60. doi: 10.1093/pm/pnv010. Epub 2015 Dec 14. PubMed 26814246 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 15, 2022

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03021096
Lead sponsor
Hospital for Special Surgery, New York
Responsible party
Sponsor
First posted
Jan 13, 2017
Start date
Jan 27, 2017
Primary completion
Dec 18, 2017
Completion
Mar 22, 2018
Results posted
Mar 4, 2025
Last update
Mar 4, 2025

Study contacts

Jacques YaDeau, MD, PhD
principal investigator · Hospital for Special Surgery, New York

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion